Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.59 -0.04 (-1.52%)
At close: Oct 1, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Interest Expenses (2014 - 2026)

Updated

Rocket Pharmaceuticals' Interest Expenses came in at $473,000 for Q2 2026, unchanged from $473,000 a year earlier and unchanged from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Interest Expenses (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Rocket Pharmaceuticals reported Interest Expenses of $1.89 million, up 0.2% year-over-year; for FY2025, it came in at $1.89 million, up 0.3% from FY2024.

  • Interest Expenses has increased in each of the last three years, though with a five-year compound annual growth rate of -23.0% (FY2020 to FY2025).
  • Going back by year, Interest Expenses was $1.89 million in FY2024 (+0.6%), $1.88 million in FY2023 (+0.7%), $1.86 million in FY2022 (-37.5%) and $2.98 million in FY2021 (-57.3%).
  • The five-year range for quarterly Interest Expenses is $463,000 (Q4 2021) to $534,000 (Q3 2021).
  • Year-over-year, Interest Expenses increased in six of the last eight quarters, with growth averaging 0.3%.
  • The fastest year-over-year change in Interest Expenses over five years came in Q2 2022 (growth of 85.3%), and the weakest in Q1 2022 (a decline of 73.2%).
  • Business Quant data shows RCKT's Interest Expenses at $473,000 (Q1 2026), $473,000 (Q4 2025) and $473,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Rocket Pharmaceuticals 288.09 Mn 288.09 Mn - 473,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 473,000.00
Mar 31, 2026 473,000.00
Dec 31, 2025 473,000.00
Sep 30, 2025 473,000.00
Jun 30, 2025 473,000.00
Mar 31, 2025 472,000.00
Dec 31, 2024 473,000.00
Sep 30, 2024 471,000.00
Jun 30, 2024 471,000.00
Mar 31, 2024 471,000.00
Dec 31, 2023 470,000.00
Sep 30, 2023 469,000.00
Jun 30, 2023 468,000.00
Mar 31, 2023 468,000.00
Dec 31, 2022 467,000.00
Sep 30, 2022 465,000.00
Jun 30, 2022 465,000.00
Mar 31, 2022 464,000.00
Dec 31, 2021 463,000.00
Sep 30, 2021 534,000.00
API Access

Rocket Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=RCKT&period=max&api_key=YOUR_API_KEY